See more : Pembridge Resources plc (PERE.L) Income Statement Analysis – Financial Results
Complete financial analysis of LHC Group, Inc. (LHCG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of LHC Group, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Chicago Atlantic BDC, Inc. (LIEN) Income Statement Analysis – Financial Results
- Commerzbank AG (CRZBF) Income Statement Analysis – Financial Results
- Vaso Corporation (VASO) Income Statement Analysis – Financial Results
- Australian Pacific Coal Limited (AQC.AX) Income Statement Analysis – Financial Results
- Forrestania Resources Limited (FRS.AX) Income Statement Analysis – Financial Results
LHC Group, Inc. (LHCG)
About LHC Group, Inc.
LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI). The Home Health Services segment offers skilled nursing, medically oriented social services and physical, occupational, and speech therapy. The Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. Its Home and Community-Based Services segment offers range of services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand. The Facility-Based Services segment treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical personnel. This segment serves patients suffering from respiratory failure, neuromuscular and cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments; and operates nursing facilities, family health center, rural health clinic, and physician practice, as well as offers physical therapy services. The HCI segment provides strategic health management services to accountable care organizations. As of December 31, 2021, it operated 557 home health services locations, 170 hospice locations, 136 community-based service locations, 11 long-term acute care hospitals with 12 locations, and 14 HCI locations. The company was founded in 1994 and is based in Lafayette, Louisiana.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.28B | 2.22B | 2.06B | 2.08B | 1.81B | 1.07B | 914.82M | 816.37M | 733.63M | 658.28M | 637.57M | 633.87M | 635.03M | 531.98M | 383.30M | 298.03M | 215.25M | 162.55M | 122.98M | 68.52M | 47.37M | 28.21M |
Cost of Revenue | 1.40B | 1.34B | 1.25B | 1.32B | 1.16B | 675.81M | 557.65M | 480.88M | 434.78M | 383.46M | 365.75M | 352.35M | 329.99M | 270.52M | 186.85M | 152.58M | 109.85M | 88.34M | 63.25M | 34.46M | 22.22M | 13.47M |
Gross Profit | 883.61M | 883.01M | 812.80M | 755.35M | 653.61M | 396.28M | 357.17M | 335.49M | 298.86M | 274.82M | 271.82M | 281.53M | 305.05M | 261.47M | 196.45M | 145.45M | 105.40M | 74.21M | 59.73M | 34.06M | 25.15M | 14.74M |
Gross Profit Ratio | 38.71% | 39.78% | 39.40% | 36.31% | 36.11% | 36.96% | 39.04% | 41.10% | 40.74% | 41.75% | 42.63% | 44.41% | 48.04% | 49.15% | 51.25% | 48.80% | 48.97% | 45.65% | 48.57% | 49.71% | 53.10% | 52.26% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 741.10M | 675.52M | 632.85M | 596.01M | 537.92M | 310.54M | 270.62M | 248.63M | 233.95M | 214.13M | 205.64M | 275.59M | 201.84M | 171.70M | 136.16M | 106.80M | 71.13M | 53.74M | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 741.10M | 675.52M | 632.85M | 596.01M | 537.92M | 310.54M | 270.62M | 248.63M | 233.95M | 214.13M | 205.64M | 275.59M | 201.84M | 171.70M | 136.16M | 106.80M | 71.13M | 53.74M | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | 23.14M | 20.92M | 0.00 | 0.00 | 0.00 | 9.48M | 14.79M | 19.24M | 15.78M | 13.93M | 11.88M | 12.32M | 7.61M | 4.72M | 0.00 | 0.00 | 0.00 | 0.00 | 39.71M | 24.31M | 15.90M | 11.12M |
Operating Expenses | 764.24M | 696.44M | 632.85M | 596.01M | 537.92M | 320.02M | 285.41M | 267.87M | 249.73M | 228.06M | 217.51M | 287.91M | 209.44M | 176.42M | 136.16M | 106.80M | 71.13M | 53.74M | 39.71M | 24.31M | 15.90M | 11.12M |
Cost & Expenses | 2.16B | 2.03B | 1.88B | 1.92B | 1.69B | 995.83M | 843.06M | 748.75M | 684.50M | 611.53M | 583.26M | 640.25M | 539.43M | 446.93M | 323.01M | 259.37M | 180.98M | 142.08M | 102.96M | 58.76M | 38.12M | 24.59M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 31.31M | 4.34M | 4.13M | 11.16M | 9.68M | 3.88M | 2.94M | 2.30M | 2.49M | 2.00M | 1.55M | 1.02M | 134.00K | 142.00K | 469.00K | 376.00K | 325.00K | 1.07M | 1.19M | 1.22M | 1.13M | 411.00K |
Depreciation & Amortization | 64.19M | 58.42M | 55.80M | 51.62M | 16.36M | 13.42M | 12.16M | 11.96M | 9.57M | 8.33M | 7.81M | 7.52M | 7.50M | 4.83M | 3.74M | 3.03M | 2.43M | 1.75M | 1.02M | -3.29M | -3.02M | -2.42M |
EBITDA | 152.33M | 216.18M | 178.11M | 151.61M | 112.01M | 78.35M | 73.86M | 69.44M | 48.41M | 48.52M | 54.31M | -6.67M | 95.60M | 89.53M | 60.29M | 38.66M | 33.76M | 20.47M | 17.13M | 6.47M | 6.23M | 1.20M |
EBITDA Ratio | 6.67% | 9.74% | 10.06% | 8.90% | 6.19% | 7.31% | 8.07% | 8.51% | 6.60% | 7.37% | 8.52% | -1.05% | 13.88% | 16.83% | 13.86% | 11.79% | 15.69% | 11.25% | 13.93% | 9.44% | 13.16% | 4.25% |
Operating Income | 88.14M | 182.24M | 178.11M | 151.61M | 111.00M | 74.68M | 70.56M | 66.34M | 45.49M | 46.76M | 54.31M | -6.38M | 95.60M | 85.05M | 60.29M | 38.66M | 34.27M | 20.47M | 20.02M | 9.75M | 9.25M | 3.62M |
Operating Income Ratio | 3.86% | 8.21% | 8.63% | 7.29% | 6.13% | 6.97% | 7.71% | 8.13% | 6.20% | 7.10% | 8.52% | -1.01% | 15.05% | 15.99% | 15.73% | 12.97% | 15.92% | 12.59% | 16.28% | 14.24% | 19.53% | 12.83% |
Total Other Income/Expenses | -31.31M | -937.00K | -4.13M | -11.16M | -9.68M | -3.35M | -2.44M | -1.85M | -2.22M | -1.75M | -1.37M | 763.00K | 671.00K | -403.00K | -11.36M | -6.92M | -3.26M | -473.00K | -5.39M | -1.12M | -1.01M | -86.00K |
Income Before Tax | 77.21M | 181.30M | 173.98M | 140.46M | 101.32M | 71.33M | 68.12M | 64.50M | 43.27M | 45.01M | 52.94M | -5.62M | 96.27M | 84.64M | 61.26M | 39.36M | 35.98M | 19.99M | 14.63M | 8.64M | 8.25M | 3.53M |
Income Before Tax Ratio | 3.38% | 8.17% | 8.43% | 6.75% | 5.60% | 6.65% | 7.45% | 7.90% | 5.90% | 6.84% | 8.30% | -0.89% | 15.16% | 15.91% | 15.98% | 13.21% | 16.72% | 12.30% | 11.90% | 12.61% | 17.40% | 12.53% |
Income Tax Expense | 16.96M | 37.69M | 36.04M | 26.61M | 22.40M | 10.94M | 22.18M | 22.85M | 14.51M | 15.86M | 17.51M | -1.97M | 31.73M | 26.74M | 18.73M | 12.15M | 10.42M | 5.36M | 5.61M | 2.40M | 2.26M | 2.75M |
Net Income | 60.25M | 143.62M | 111.60M | 95.73M | 63.57M | 50.11M | 36.58M | 32.34M | 21.84M | 22.34M | 27.44M | -13.24M | 48.80M | 57.81M | 30.20M | 19.59M | 20.59M | 10.10M | 9.31M | 2.84M | 2.84M | 787.00K |
Net Income Ratio | 2.64% | 6.47% | 5.41% | 4.60% | 3.51% | 4.67% | 4.00% | 3.96% | 2.98% | 3.39% | 4.30% | -2.09% | 7.68% | 10.87% | 7.88% | 6.57% | 9.57% | 6.21% | 7.57% | 4.15% | 6.00% | 2.79% |
EPS | 1.97 | 4.57 | 3.56 | 3.07 | 2.29 | 2.83 | 2.08 | 1.86 | 1.27 | 1.31 | 1.54 | -0.73 | 2.69 | 3.22 | 1.69 | 1.10 | 1.20 | 0.69 | 0.77 | 0.24 | 0.24 | 0.07 |
EPS Diluted | 1.97 | 4.57 | 3.56 | 3.07 | 2.29 | 2.79 | 2.07 | 1.84 | 1.26 | 1.30 | 1.53 | -0.73 | 2.68 | 3.20 | 1.69 | 1.10 | 1.20 | 0.69 | 0.77 | 0.23 | 0.24 | 0.06 |
Weighted Avg Shares Out | 30.66M | 31.43M | 31.37M | 31.21M | 27.77M | 17.72M | 17.56M | 17.41M | 17.23M | 17.05M | 17.85M | 18.27M | 18.12M | 17.96M | 17.86M | 17.76M | 17.09M | 14.63M | 12.09M | 12.09M | 11.93M | 11.76M |
Weighted Avg Shares Out (Dil) | 30.66M | 31.43M | 31.37M | 31.21M | 27.77M | 17.96M | 17.68M | 17.55M | 17.32M | 17.13M | 17.90M | 18.27M | 18.23M | 18.07M | 17.90M | 17.83M | 17.10M | 14.68M | 12.15M | 12.11M | 12.08M | 12.24M |
LHC Group (LHCG) & SCP Health to Offer Home Health Services
LHC Group and SCP Health Partner to Provide Advanced Clinical Care in the Home
LHC Group announces second quarter 2021 earnings release and conference call dates
LHC Group (LHCG) Boosts Home Health, Hospice Arms With Buyouts
Provident Healthcare Partners Advises Heart 'n Home Hospice in its Acquisition by LHC Group
LHC Group acquisitions announced and finalized across seven states
Harris Williams Advises Heart of Hospice, LLC on its Pending Sale to LHC Group, Inc.
Here's Why You Should Retain LHC Group (LHCG) Stock for Now
LHC Group (LHCG) Expands Hospice Presence with New Buyout
LHC Group to purchase Heart of Hospice
Source: https://incomestatements.info
Category: Stock Reports